Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine
Sigaroudi, Ali; Kullak-Ublick, Gerd A; Weiler, Stefan (2016). Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine. European Journal of Clinical Pharmacology, 72(3):377-378.
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Life Sciences > Pharmacology
Health Sciences > Pharmacology (medical) |
Language: | English |
Date: | 2016 |
Deposited On: | 25 Oct 2016 13:01 |
Last Modified: | 15 Oct 2024 01:42 |
Publisher: | Springer |
ISSN: | 0031-6970 |
OA Status: | Green |
Publisher DOI: | https://doi.org/10.1007/s00228-015-1991-z |
PubMed ID: | 26631062 |
Permanent URL
https://doi.org/10.5167/uzh-126866Download
Links
Statistics
Citations
Dimensions.ai Metrics